enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. List of United States Supreme Court patent case law

    en.wikipedia.org/wiki/List_of_United_States...

    For the purpose of calculating damages in a patent infringement action, the infringing "article of manufacture" may be defined as either an end product sold to a consumer or as a component of that product. 35 U.S.C. §289: The relevant text of the Patent Act encompasses both an end product sold to a consumer as well as a component of that product.

  3. Intel wins US appeal to overturn $2.18 billion VLSI patent ...

    www.aol.com/news/intel-wins-us-appeal-overturn...

    WASHINGTON (Reuters) -A U.S. appeals court on Monday threw out a $2.18 billion patent-infringement award won by patent owner VLSI Technology against Intel Corp, overturning one of the largest ...

  4. Microsoft hit with $242 million US verdict in Cortana patent ...

    www.aol.com/news/microsoft-hit-242-million-us...

    Microsoft must pay patent owner IPA Technologies $242 million, a federal jury in Delaware said on Friday after determining that Microsoft's Cortana virtual-assistant software infringed an IPA patent.

  5. List of United States patent law cases - Wikipedia

    en.wikipedia.org/wiki/List_of_United_States...

    Held that an assignee of a geographically limited patent right could not bring an action in the assignee's own name. Now obsolete. Hotchkiss v. Greenwood - Supreme Court, 1850. Introduced the concept of non-obviousness as patentability requirement in U.S. patent law. Le Roy v. Tatham - Supreme Court, 1852. "It is admitted that a principle is ...

  6. Amgen Inc v. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Amgen_Inc_v._Sanofi

    Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering drugs failed to satisfy the enablement clause of §112 of the Patent Act, 35 U.S.C. § 112(a).

  7. Bayer's patent for blood thinner Xarelto invalid, UK ... - AOL

    www.aol.com/news/bayers-patent-blood-thinner...

    Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...

  8. United States v. Arthrex, Inc. - Wikipedia

    en.wikipedia.org/wiki/United_States_v._Arthrex,_Inc.

    Arthrex, Inc., 594 U.S. ___ (2021), was a United States Supreme Court case related to the Appointments Clause of the United States Constitution as it related to patent judges on the Patent Trial and Appeal Board (PTAB). In a complex decision, the Court ruled that these judges were considered "principal officers" under the Appointments Clause ...

  9. United States Patents Quarterly - Wikipedia

    en.wikipedia.org/wiki/United_States_Patents...

    The United States Patents Quarterly (U.S.P.Q.) is a United States legal reporter published by the Bloomberg Industry Group [1] in Washington, D.C. The U.S.P.Q. covers intellectual property cases including patents, copyrights, trademarks, and trade secrets, from 1913 to the present. The publisher stopped the sequence of volume numbers and ...